Biochronomer™ technology

Expert Opinion on Drug Delivery

Volumn 2, Issue 1, 2005, Pages 169-183

  Heller, Jorge ^a   Barr, John ^b  

^a AP Pharma ^*  (United States)

^b AP Pharma   (United States)

Author keywords

Bioerodible polymer; Clinical trials; Granisetron; Mepivacaine; Nausea; Poly(ortho ester); Postoperative pain; Semisolid; Surface erosion

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOXYMETHYLCELLULOSE; CARMUSTINE; COPOLYMER; DNA VACCINE; DRUG SOLVENT; ERUCIC ACID; GENTAMICIN; GONADORELIN DERIVATIVE; GRANISETRON; HUMAN GROWTH HORMONE; LOCAL ANESTHETIC AGENT; MACROGOL; MEPIVACAINE; MICROSPHERE; NAKED DNA; OPIATE; PLASMID DNA; POLY(ORTHO ESTER); POLYANHYDRIDE; POLYCAPROLACTONE; POLYESTER; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; POLYSORBATE; RICINOLEIC ACID; SEBACIC ACID; UNINDEXED DRUG; SEROTONIN ANTAGONIST;

BIODEGRADABILITY; CHEMICAL COMPOSITION; CLINICAL TRIAL; DEHYDRATION; DRUG CONFORMATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG RELEASE; DRUG SAFETY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROLYTE DISTURBANCE; ENCAPSULATION; ENDOSOME; GLIOBLASTOMA; HUMAN; METABOLIC ALKALOSIS; NAUSEA AND VOMITING; NONHUMAN; OSTEOMYELITIS; PHYSICAL CHEMISTRY; POSTOPERATIVE PAIN; PROSTATE CANCER; REVIEW; SIDE EFFECT; TOXICITY TESTING; ARTICLE; CHEMISTRY; DELAYED RELEASE FORMULATION; GEL; HYDROLYSIS; NAUSEA; SOLUBILITY; SURFACE PROPERTY; TIME;

ANESTHETICS, LOCAL; CHEMISTRY, PHARMACEUTICAL; CLINICAL TRIALS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; GELS; GRANISETRON; HUMANS; HYDROLYSIS; MEPIVACAINE; NAUSEA; PAIN, POSTOPERATIVE; POLYANHYDRIDES; POLYESTERS; POLYMERS; SEROTONIN ANTAGONISTS; SOLUBILITY; SURFACE PROPERTIES; TIME FACTORS; VACCINES, DNA;

EID: 12344258040     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2.1.169     Document Type: Review

References (45)

1. HELLER J: Use of polymers in controlled release. In: Sustained and Controlled Release Delivery Systems. ROBINSON JR, LEE VHL (Eds.) Marcel Dekker, New York (1987):179-212.
2. BYENGMOON J, BAE YH, LEE DS, KIM SW: Biodegradable block copolymers as injectable drug-delivery systems. Nature (1997) 388:860-862.
3. DAHIYAT BI, RICHARDS M, LEONG KW: Controlled release from poly(phosphoester) matrices. J. Control. Rel. (1995) 33 13-21.
4. HELLER J: Controlled release of biologically active compounds from bioerodible polymers. Biomaterials (1980) 1:51-57.
5. Von BURKESRODA F, SCHEDL L, GOPFERICH A: Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials (2002) 23:4221-4231.
6. DADSETAN M, CHRISTENSON EM, UNGER F et al.: In vivo biocompatibility and biodegradation of poly(ethylene carbonate). J. Control. Rel. (2003) 93:259-270.
7. ACEMOGLU M, NIMMERFALL F, BANTLE S, STOLL GH: Poly(ethylene carbonate)s, part I: Synthesis and structural effects on biodegradation. J. Control. Rel. (1995) 49:263-276.
8. STOLL GH, NIMMERFALL F, ACEMOGLU M et al.: Poly(ethylene carbonate)s, part II: degradation mechanisms and parenteral delivery of bioactive agents. J. Control. Rel. (2001) 76 209-225.
9. YOLLES S, ELDRIDGE JE, WOODLAND JHR: Sustained delivery of drugs from polymer/drug mixtures. Polym. News (1970) 1:9-12.
10. KULKARNI RK, MOORE EG, HEGYELI AF, LEONARD F: Biodegradable poly(lactic acid) polymers J. Biomed Mater. Res. (1971) 5 169-181.
11. HUGGINS C, STEVENS RE, HODGES CV: Studies on prostatic cancer. II. The effect of castration in advanced carcinoma of the prostate gland. Arch. Surg. (1941) 43:209-223.
12. KHAN MA, HEALY MS, BERNSTEIN H: Low temperature fabrication of protein-loaded microspheres. Proc. Int. Symp. Control. Rel. Bioact. Mater. (1992) 19:518-519.
13. JOHNSON OFL, CLELAND JF, LEE HJ et al.: A month-long effect from a single injection of microencapsulated human growth hormone. Nat. Med. (1996) 2:795-799.
14. SCHINDLER A, JEFFCOAT R, KIMMEL GL, PITT CG, WALL ME, ZWEIDINGER R: Biodegradable polymers for sustained drug delivery. In: Contemporary Topics in Polymer Science. Pearce EM, Schaefgen JR (Eds) Plenum Press, New York (1977) 2:251-289.
15. PITT CG, GRATZL MM, JEFFCOAT AR, ZWEIDINGER R, SCHINDLER A: Sustained drug delivery systems II. Factors affecting release rates from poly(ε-caprolactone) and related biodegradable polyesters. J. Pharm. Sci. (1979) 68:1534-1538.
16. PERRIN D, ENGLISH J: Polycaprolactone: Handbook of Biodegradable Polymers - Drug Targeting and Delivery. DOMB A, KOST J, WISEMAN D (Eds) Harwood Academic Publishers, 7000 Chur, Switzerland (1997) 7:63-78.
17. BUCHER JE, SLADE WC: The anhydrides of isophthalic and terephthalic acids. J. Am. Chem. Soc., (1909) 31:1319-1321.
18. ROSEN HB, CHANG J, WNEK GE, LINHARDT RJ, LANGER R: Bioerodible polyanhydrides for controlled drug delivery. Biomaterials (1983) 4:131-133.
19. LEONG KW, BROTT BC, LANGER R: Bioerodible polyanhydrides as drug carrier matrices I: Characterization, degradation and release characteristics. J. Biomed. Mater. Res. (1985) 19:941-955.
20. LEONG KW, D'AMORE PD, MARLETTA M, LANGER R: Bioerodible polyanhydrides as drug carrier matrices II: Biocompatibility and chemical reactivity. J. Biomed Mater. Res. (1986) 20:51-64.
21. BREM H, LANGER R: Polymer-based drug delivery to the brain. Science & Medicine (1996) 3:2-11.
22. DOMB A, MANIAR M: Absorbable biopolymers derived from dimer fatty acid. J. Polymer Sci., Part A: Polymer Chem. (1993) 31 1275-1285.
23. LI LC, DENG J, STEPHENS D: Polyanhydride implants for antibiotic delivery- from bench to the clinic. Adv. Drug Deliv. Rev. (2002) 54:963-968.
24. TEOMIN D, NYSKA A, DOMB A: Ricinoleic acid-based biopolymers. J. Biomed. Mater. Res. (1999) 45:258-276.
25. HELLER J, BARR J: Poly(ortho esters) - from concept to reality. Biomacromolecules (2004) 5:1625-1632.
26. HELLER J: Poly(ortho esters). Adv. in Polymer Sci. (1993) 107:41-92.
27. HELLER J, BARR J, NG SY, SCHWACH-ABDELLAOUI K, GURNY R: Poly(ortho esters): synthesis, characterization, properties and uses. Adv. Drug Deliv. Rev. (2002) 54:1015-1039.
28. NGUYEN TH, HIMMELSTEIN KJ, HIGUCHI T: Some equilibrium and kinetics of water sorption in poly(ortho esters). Int. J. Pharm. (1985) 25:1-12.
29. SCHWACH-ABDELLAOUI K, HELLER J, GURNY R: Hydrolysis and erosion studies of autocatalyzed poly(ortho ester) containing lactoyl-lactyl acid dimers. Macromolecules (1999) 32:301-307.
30. ROTHEN-WEINHOLD A, SCHWACH-ABDELLAOUI K, BARR J et al.: Release of BSA from poly(ortho ester) extruded thin strands. J. Control. Rel. (2001) 71:31-37.
31. ZENTNER GM, RATHI, R, SHIH C et al.: Biodegradable block copolymers for the delivery of proteins and water-insoluble drugs. J. Control. Rel., (2000) 72:203-215.
32. ROYALS MA, FUJITA SM, YEWEY GL, RODRIGUEZ J, SCHULTHEISS PC, DUNN RL: Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys. J. Biomed. Mater. Res. (1999) 45:231-239.
33. SCHWACH-ABDELLAOUI K, GURNY R, HELLER J, BARR J: Control of molecular weight for autocatalyzed poly(ortho esters) obtained by polycondensation reaction. Int. J. Polym. Anal. Charact. (2002) 7:145-161.
34. TUCKER GT, MATHER LE: Clinical pharmacokinetics of local anaesthetics. Clin. Pharmacokinet. (1979) 4:241-248.
35. COATES A, ABRAHAM S, KAYE SB et al.: On the receiving end - patient perception of the side-effects of cancer chemotherapy. Eur. J. Cancer Clin. Oncol. (1983) 19:203-208.
36. TRIOZZI PL, LASZLO J: Optimum management of nausea and vomiting in cancer chemotherapy. Drugs (1987) 34:136-149.
37. DUBENSKY TW, LIU MA, ULMER JB: Delivery systems for gene-based vaccines. Mol. Med. (2000) 6:723-732.
38. SINGH M, O'HAGAN D: Advances in vaccine adjuvants. Nat. Biotechnol. (1999) 17:1075-1081.
39. WANG C, QING GE, TING D et al.: Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nature Materials (2004) 3:190-196.
40. KISSEL T, LI YX, VOLLAND C, GORICH S, KONEBERG R: Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks. J. Control. Release (1996) 39:315-326.
41. PISTEL KF, BREITENBACH A, ZANGE-VOLLAND R, KISSEL T: Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol -g-poly(D,L-lactic-co glycolic acid). J. Control. Release (2001) 73:7-20.
42. DOMB AJ, LANGER R: Solid-state and solution stability of polyanhydrides and polyesters. Macromolecules (1989) 22 2117-2122.
43. ROHR UD, MARKMANN S, OBERHOFF C et al.: ONCOGEL™; a technological break through in local treatment of paclitaxel sensitive cancers. Proc. Int. Symp. Control. Rel. Bioact. Mater. (2002) 29 33-34.
44. ZHAO Z, CHAUBAL M, SU G, JIANG T, DANG W: In vitro degradation studies of polylactofates - a copolymer of lactide and phosphate. Proc. Int. Symp. Control. Rel. Bioact. Mater. (2000) 27:652-653.
45. BYEONGMOON J, KIBBEY MR, BIRNBAUM C, WON Y-Y, GUTOWSKA A: Thermogelling biodegradable polymers with hydrophilic backbones: PEG-g PLGA. Macromolecules (2000) 33:8317-8322.